Abstract: An Inconel 625 alloy with high aluminum content and a preparation method thereof are provided. The alloy includes following components by mass percentage: chromium 5˜13%, ferrum 5%, niobium 4.15%, molybdenum 10%, aluminum 5˜9% and a rest is nickel. The preparation method includes: step (1): weighing reactive materials according to a preset ratio and putting the reactive materials into a planetary ball miller for ball milling; step (2): pressing the ball milled reactive materials into a cake-shaped slab; step (3) putting the cake-shaped slab into a reactor and putting an igniter on the cake-shaped slab, then adding the reactor with protective gas, heating up until a self-propagating reaction occurs in the reactor, thereby obtaining a base alloy; step (4): performing secondary smelting on the base alloy to obtain an ingot; step (5): performing a solution treatment on the ingot to obtain the Inconel 625 alloy with high aluminum content.

Abstract: An Inconel 625 alloy with high aluminum content and a preparation method thereof are provided. The alloy includes following components by mass percentage: chromium 5˜13%, ferrum 5%, niobium 4.15%, molybdenum 10%, aluminum 5˜9% and a rest is nickel. The preparation method includes: step (1): weighing reactive materials according to a preset ratio and putting the reactive materials into a planetary ball miller for ball milling; step (2): pressing the ball milled reactive materials into a cake-shaped slab; step (3) putting the cake-shaped slab into a reactor and putting an igniter on the cake-shaped slab, then adding the reactor with protective gas, heating up until a self-propagating reaction occurs in the reactor, thereby obtaining a base alloy; step (4): performing secondary smelting on the base alloy to obtain an ingot; step (5): performing a solution treatment on the ingot to obtain the Inconel 625 alloy with high aluminum content.

Abstract: The present invention provides a novel use of fibroblast growth factor 2 (FGF-2), i.e., a use of FGF-2 in preparation of medicine. The uses of the medicine are the following (a) and/or (b) and/or (c): (a) the prevention and/or treatment of lung injury; (b) the prevention and/or treatment of influenza; (c) the prevention and/or treatment of diseases caused by influenza viruses.

Abstract: The present invention provides a novel use of fibroblast growth factor 2 (FGF-2), i.e., a use of FGF-2 in preparation of medicine. The uses of the medicine are the following (a) and/or (b) and/or (c): (a) the prevention and/or treatment of lung injury; (b) the prevention and/or treatment of influenza; (c) the prevention and/or treatment of diseases caused by influenza viruses.

Abstract: A method for monitoring a main machine, a monitoring apparatus and a main machine are provided. The method for monitoring the main machine includes paging, by a monitoring apparatus, a main machine within an effective area, returning, by a main machine being paged, apparatus information of the main machine; determining at least one main machine as a monitored main machine according to the apparatus information returned by the at least one main machine; establishing a monitoring connection relationship with each monitored main machine; and monitoring an emergent event of the at least one monitored main machine or inquiring about a working status of the at least one monitored main machine by using the monitoring connection relationship established.